• Explore /
  • Poster
  • / TOUCAN: A randomised phase II trial of carboplatin and gemcitabine +/- vandetanib in first line treatment of advanced urothelial cell cancer in patients who are not suitable to receive cisplatin.

TOUCAN: A randomised phase II trial of carboplatin and gemcitabine +/- vandetanib in first line treatment of advanced urothelial cell cancer in patients who are not suitable to receive cisplatin.

Abstract Poster

Authors

null

Robert J. Jones

University of Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom

Robert J. Jones , Simon J. Crabb , John D. Chester , Tony Elliott , Robert Anthony Huddart , Alison J. Birtle , Linda Evans , Jason Francis Lester , Chao Huang , Angela Claire Casbard , Tracie-Ann Madden , Gareth Griffiths

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Prostate Cancer; Urothelial Carcinoma; Penile, Urethral, and Testicular Cancers

Track

Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, and Testicular Cancers

Sub Track

Urothelial Carcinoma

Clinical Trial Registration Number

68146831

Citation

J Clin Oncol 34, 2016 (suppl 2S; abstr 448)

DOI

10.1200/jco.2016.34.2_suppl.448

Abstract #

448

Poster Bd #

J19

Abstract Disclosures

Similar Posters

First Author: Thomas Powles

First Author: Takahiro Yoneyama

First Author: Jun Ni

First Author: Matt D. Galsky